long-term effects of glp-1 receptor agonists Glucagon-Like Peptide-1 Agonist Use in People Living with Type 2 Diabetes Mellitus and Chronic Kidney Disease: A Narrative Review the Key Evidence with Practical Considerations | Diabetes Therapy Unlocking the broad health benefits

F., Larijani, B., Heshmat, R., Fakhrzadeh, H., Radjabipour, B., Toliat, T., & Raza, M

Clinical guidance generally advises avoiding this class in patients with a pancreatitis history unless there's no reasonable alternative

Inzucchi SE, Zinman B, Fitchett D, Wanner C, Ferrannini E, Schumacher M, et al

Paraventricular Nucleus Activation c-Fos Neuronal Mapping Systemic administration of PT-141 in rats activates neurons in the paraventricular nucleus (PVN) of the hypothalamus, demonstrated by increased c-Fos immunoreactivity the standard molecular marker of acute neuronal activation

Morphological abnormalities were observed only in the dopaminergic cells, and mitochondrial functional impairments, uneven cellular distribution of organelles, dissipation of mitochondrial membrane potential ( m ) and perturbations in mitochondrial network structure and connectivity were found [125]